Home > Geron Salary

Geron Salary

  • 62
  • 27
  • 91
Geron average salary is $66,561, median salary is $66,920 with a salary range from $58,338 to $77,860.
Geron salaries are collected from government agencies and companies. Each salary is associated with a real job position. Geron salary statistics is not exclusive and is for reference only. They are presented "as is" and updated regularly.
Low
58,338
Average
66,561
Median
66,920
High
77,860
Total 5 Geron Salaries. Sorted by Date, page 1
Ranked By:
Job Title Salaries City Year More info
Project Engineer Iv 77,860-77,860 Gainesville, FL, 32601 2011 Geron Project Engineer Iv Salaries (2)
Geron Gainesville, FL Salaries
Engineering Intern Iii 58,366-58,366 Gainesville, FL, 32601 2011 Geron Engineering Intern Iii Salaries (1)
Geron Gainesville, FL Salaries
Project Manager - Iv 70,960-70,960 Gainesville, FL, 32601 2011 Geron Project Manager - Iv Salaries (1)
Geron Gainesville, FL Salaries
Designer 58,338-65,740 Gainesville, FL, 32601 2010 Geron Designer Salaries (2)
Geron Gainesville, FL Salaries
Project Engineer Iv 68,100-68,100 Tampa, FL, 33601 2010 Geron Project Engineer Iv Salaries (2)
Geron Tampa, FL Salaries
Calculate how much you could earn

It's FREE. Based on your input and our analysis.     How we do it?

All fields are required for calculation accuracy.

  • We will send you an email to access your personalized report.
  • We won’t share your email address

Geron salary is full-time annual starting salary. Intern, contractor and hourly pay scale vary from regular exempt employee. Compensation depends on work experience, job location, bonus, benefits and other factors.

Real Jobs Salary - Salary List
Calculate Your Salary Ranking
Geron Jobs
See more Geron Jobs»
Search All Jobs

JobsOpenHiring – Find open jobs faster
Geron... Information
  • Geron Corporation
  • Industry: BioTech/Drugs
  • City: Menlo Park, CA
  • Geron Corporation is a development stage biopharmaceutical company focused on developing and commercializing therapeutic and diagnostic products for applications in oncology and regenerative medicine, and research tools for drug discovery. The Company's product development programs are based upon three patented core technologies: telomerase, human embryonic stem cells and nuclear transfer. The Company is working to develop anti-cancer therapies based on telomerase inhibitors, oncolytic (cancer-killing) viruses and telomerase vaccines. The Company also intends to continue to develop and commercialize products using telomerase as a marker for cancer diagnosis, prognosis, patient monitoring and screening.